Prostate Cancer Risk Management

Prostate Cancer Risk Management

There is no organised screening programme for prostate cancer but an informed choice programme, Prostate Cancer Risk Management, has been introduced.

If you are worried about a specific problem, or otherwise worried about the risks of cancer, then you should talk to your GP.

Why isn't there a national screening programme for prostate cancer?

All screening programmes cause some harm. This could include false alarms, inducing anxiety, and the treatment of early disease which would not otherwise have become a problem.

When considering population screening programmes the benefits and harms must be carefully assessed, and the benefits should always outweigh the harms.

Until there is clear evidence to show that a national screening programme will bring more benefit than harm, the NHS will not be inviting men who have no symptoms for prostate cancer screening.

In 1968, Wilson and Jungner of the World Health Organisation developed ten principles which should govern a national screening programme. These are:

The condition is an important health problem
Its natural history is well understood
It is recognisable at an early stage
Treatment is better at an early stage
A suitable test exists
An acceptable test exists
Adequate facilities exist to cope with abnormalities detected
Screening is done at repeated intervals when the onset is insidious
The chance of harm is less than the chance of benefit
The cost is balanced against benefit

To date, prostate cancer screening fulfils only the first condition. See the Health Technology Assessment Programme's monograph Diagnosis, management and screening of early localised prostate cancer: a review. for details. The UK National Screening Committee has recommended that a prostate cancer screening programme should not be introduced in England at this time.

Although evidence does not yet support population screening for prostate cancer. there is considerable demand for the PSA test amongst men worried about the disease. In response to this the Government has introduced a PSA Informed Choice Programme, Prostate Cancer Risk Management.

The key elements are the provision of high quality information for men requesting the test. This should enable men to decide whether or not to have the test based on the available evidence about risks and benefits. Improvements to the PSA test will also be made. The office of the NHS Cancer Screening Programmes manages this work.